May 22, 2025

Benitec Biopharma Inc. (BNTC) Stock Analysis: Unveiling an 88% Potential Upside in Biotech

Investors seeking high-growth opportunities in the biotechnology sector may find themselves captivated by Benitec Biopharma Inc. (NASDAQ: BNTC). With an impressive potential upside of 88.18%, the company’s stock is drawing..

Sprout Social, Inc (SPT) Stock Analysis: Unveiling a 34% Upside Potential

Sprout Social, Inc (SPT), a prominent player in the technology sector, operates in the dynamic software application industry. Headquartered in Chicago, Illinois, Sprout Social is known for its comprehensive social..

Health Catalyst, Inc (HCAT) Stock Analysis: 116% Potential Upside in the Health Information Services Sector

Health Catalyst, Inc (NASDAQ: HCAT), a prominent player in the health information services industry, presents a compelling opportunity for investors seeking exposure to the healthcare sector. With a market capitalization..

Sanara MedTech Inc. (SMTI) Investor Outlook: Unpacking a 57.96% Potential Upside

Sanara MedTech Inc. (NASDAQ: SMTI), a prominent player in the healthcare sector, specializes in developing and distributing advanced medical instruments and supplies. Based in Fort Worth, Texas, the company has..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Uncovering a 296% Upside Potential

Candel Therapeutics, Inc. (NASDAQ: CADL), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment and remarkable growth potential. The..

Terns Pharmaceuticals (TERN) Stock Analysis: A Potential 539% Upside in the Biotech Arena

Terns Pharmaceuticals, Inc. (TERN), a clinical-stage biopharmaceutical company, continues to capture the attention of investors with its robust pipeline targeting oncology and obesity. Headquartered in Foster City, California, Terns is..

TruBridge, Inc. (TBRG) Stock Analysis: Exploring a 21.12% Potential Upside in Health Information Services

TruBridge, Inc. (NASDAQ: TBRG), a key player in the healthcare sector, is garnering significant attention from investors with its potential 21.12% upside. Specializing in health information services, TruBridge provides a..

Immutep Limited (IMMP) Stock Analysis: Exploring a 389% Potential Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, Immutep Limited (NASDAQ: IMMP) presents a compelling opportunity. Based in Sydney, Australia, this late-stage biotechnology company specializes in developing innovative LAG-3..

Tvardi Therapeutics, Inc. (TVRD): Analyst Consensus Highlights 55% Potential Upside for Investors

Tvardi Therapeutics, Inc. (TVRD), a burgeoning player in the biotechnology sector, is generating significant buzz among investors with its innovative approach to tackling cancer, chronic inflammation, and fibrosis diseases. Based..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring a 124% Potential Upside in the Medical Devices Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), a healthcare innovator based in Israel, operates in the medical devices industry with a focus on revolutionizing tomographic imaging. Despite its recent market challenges, analysts..

Varex Imaging Corporation (VREX) Stock Analysis: Unveiling a 117% Potential Upside with Strong Buy Ratings

Varex Imaging Corporation (NASDAQ: VREX) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Salt Lake City, Utah, is renowned..

Phathom Pharmaceuticals, Inc. (PHAT) Investor Outlook: Analyzing the 351.92% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a burgeoning player in the biotechnology sector, is currently making waves with its promising pipeline of gastrointestinal treatments. Headquartered in Florham Park, New Jersey, this..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 300% Potential Upside in the Medical Device Sector

For investors eyeing opportunities in the healthcare sector, particularly in medical devices, Senseonics Holdings, Inc. (SENS) presents an intriguing proposition. This commercial-stage medical technology company, headquartered in Germantown, Maryland, is..

Alumis Inc. (ALMS) Stock Analysis: Exploring a 344.56% Potential Upside in the Biotech Sector

Alumis Inc. (NASDAQ: ALMS), a notable player in the biotechnology industry, is capturing investor attention with its substantial potential upside of 344.56%. As a clinical-stage biopharmaceutical company, Alumis is dedicated..

Cidara Therapeutics (CDTX) Stock Analysis: A Biotech Contender with a 55% Upside Potential

Cidara Therapeutics, Inc. (NASDAQ: CDTX) has positioned itself as a promising player in the biotechnology sector, with a focus on developing targeted therapies for life-threatening conditions, including cancers and serious..

Aurora Cannabis Inc. (ACB) Stock Analysis: Examining Growth Amid Market Challenges

Aurora Cannabis Inc. (NYSE: ACB) continues to be a focal point in the cannabis industry, offering a mix of potential and risk that captures the attention of investors. As a..

Pacific Biosciences of California (PACB) Stock Analysis: Navigating the Healthcare Sector with a Potential 106.61% Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, is making waves with its advanced sequencing solutions designed to tackle genetically complex problems. Despite a..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring a 393% Potential Upside in the Biotech Sector

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is currently capturing the attention of investors with its significant potential upside of 393.30%. Trading at $5.01 per share, the company presents a compelling opportunity,..

UroGen Pharma Ltd. (URGN) Stock Analysis: A High-Stakes Bet with a Potential 643% Upside

UroGen Pharma Ltd. (NASDAQ: URGN) is catching the attention of investors with its striking potential for a 643.41% upside, according to the latest analyst ratings. Operating in the dynamic biotechnology..

Outset Medical, Inc. (OM): Investor Outlook Reveals 29% Upside Potential Amidst Analyst Confidence

Outset Medical, Inc. (NASDAQ: OM), a pioneering player in the healthcare sector with a focus on medical devices, has been generating buzz among investors due to its innovative approach to..

Search

Funds

May 22, 2025

Search

Funds

May 22, 2025

FTSE 100

Funds